Most likely, because a special subtype of IIM, anti-MDA5-antibody-positive (anti-MDA5+) dermatomyositis, is usually associated with rapidly progressive ILD. The gene discussed is IFIH1; the disease is acquired idiopathic inflammatory myopathy.